Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries I-Mab ADR (NQ: IMAB ) 1.720 +0.140 (+8.86%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 12, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about I-Mab ADR < Previous 1 2 3 4 5 6 Next > Super Micro Computer, Rayonier Advanced Materials And Some Other Big Stocks Moving Lower On Tuesday January 10, 2023 U.S. stocks traded slightly higher, with the Dow Jones gaining around 30 points on Tuesday. Here are some big stocks recording losses in today’s session. Via Benzinga Why Enovix Shares Are Trading Lower By 43%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session January 04, 2023 Gainers Vivos Therapeutics, Inc. (NASDAQ: VVOS) shares surged 204% to $2.25 after the company announced it received FDA 510(k) clearance for its DNA oral appliance for the treatment of obstructive... Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session January 04, 2023 Via Benzinga What 4 Analyst Ratings Have To Say About I-MAB August 31, 2022 Analysts have provided the following ratings for I-MAB (NASDAQ:IMAB) within the last quarter: Via Benzinga Alibaba, XPeng, Dada Nexus And Some Other Big Stocks Moving Higher On Wednesday January 04, 2023 U.S. stocks traded mixed, with the Dow Jones dropping around 20 points on Wednesday. Here are some big stocks recording gains in today’s session. Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session November 15, 2022 Gainers Azenta (NASDAQ:AZTA) shares rose 32.5% to $61.74 during Tuesday's pre-market session. The company's market cap stands at $4.6 billion. As per the news, the Q4 earnings report came out... Via Benzinga 12 Health Care Stocks Moving In Friday's Pre-Market Session November 04, 2022 Gainers Incannex Healthcare (NASDAQ:IXHL) shares moved upwards by 30.7% to $5.19 during Friday's pre-market session. The market value of their outstanding shares is at $316.2 million. Via Benzinga I-Mab (NASDAQ:IMAB) Investor Notice: Investigation over Potential Wrongdoing October 20, 2022 San Diego, CA -- (SBWIRE) -- 10/20/2022 -- An investigation was announced for current long-term investors in shares of I-Mab (NASDAQ:IMAB) over potential breaches of fiduciary duties by certain... Via SBWire Hony Capital Switches SPAC IPO Focus from U.S. to Hong Kong September 28, 2022 Key Takeaways: Everest Acquisition Corporation, a SPAC co-funded by Hony Capital and ABCI Capital, applied to list in Hong Kong with the aim of acquiring companies in the healthcare, consumer goods and... Via Benzinga Marathon Digital, Coinbase Global And Some Other Big Stocks Moving Higher In Today's Pre-Market Session September 27, 2022 U.S. stock futures traded higher this morning after recording losses in the previous session. Here are some big stocks moving higher in today’s pre-market trading session. Via Benzinga Why Kiora Pharmaceuticals Is Trading Lower By Around 22%; Here Are 26 Stocks Moving Premarket September 27, 2022 Gainers 9 Meters Biopharma, Inc. (NASDAQ: NMTR) rose 31.4% to $0.2720 in pre-market trading after the company disclosed final results from Phase 2 VIBRANT study, End-of-Phase 2 meeting with the FDA for... Via Benzinga Week In Review: METiS, A US-China AI Biotech, Acquires Pan-RAF Inhibitor In $482 Million Deal September 17, 2022 METiS Therapeutics in-licensed global rights to a pan-RAF inhibitor program from Korea’s Voronoi in a deal worth up to $482 million. METiS will pay only $1.7 million upfront, with provision for $480.5... Via Talk Markets NASDAQ:IMAB Investor Notice: Investigation over Possible Securities Laws Violations by I-Mab September 12, 2022 San Diego, CA -- (SBWIRE) -- 09/12/2022 -- An investigation was announced concerning potential securities laws violations by I-Mab in connection with certain financial statements. Via SBWire Week In Review: Biocytogen, A Genetically Modified Animal Models Company, Stages $60 Million IPO September 03, 2022 Beijing Biocytogen Pharma completed a $60 million IPO on the Hong Kong Exchange for its genetically modified animal and cell model business, which it offers to pharmaceutical/biotech companies.... Via Talk Markets INVESTIGATION NOTICE: The Schall Law Firm Encourages Investors in I-Mab with Losses of $100,000 to Contact the Firm September 01, 2022 From The Schall Law Firm Via Business Wire INVESTIGATION ALERT: The Schall Law Firm Encourages Investors in I-Mab with Losses of $100,000 to Contact the Firm August 31, 2022 From The Schall Law Firm Via Business Wire This Analyst Cuts Price Target On Snap? Here Are 5 Other Price Target Changes For Wednesday August 31, 2022 Citigroup cut the price target on Snap Inc. (NYSE: SNAP) from $16 to $10. Citigroup analyst Ronald Josey also downgraded the stock from Buy to Neutral. Snap shares fell 7% to $9.31 in pre-market... Via Benzinga Earnings Scheduled For August 30, 2022 August 30, 2022 Companies Reporting Before The Bell • Photronics (NASDAQ:PLAB) is likely to report quarterly earnings at $0.50 per share on revenue of $210.00 million. Via Benzinga Week In Review: China And The US May Settle De-Listing/Accounting Impasse August 27, 2022 China and the US are close to solving the accounting rules crisis that threatens to de-list 261 China companies from US exchanges. The list of affected biopharma companies includes BeiGene, Legend Bio,... Via Talk Markets Bed Bath & Beyond, America's Car-Mart And Some Other Big Stocks Moving Lower On Thursday August 18, 2022 Bed Bath & Beyond Inc. (NASDAQ: BBBY) fell 23.3% to $17.71 following a Form 144 filing by RC Ventures, which suggested the firm proposed to sell 7.78 million common shares and certain call options.... Via Benzinga Stocks That Hit 52-Week Lows On Thursday August 18, 2022 During Thursday's trading, 62 companies set new 52-week lows. Via Benzinga This Analyst Cuts I-Mab's Price Target By 43% August 17, 2022 I-Mab (NASDAQ: IMAB) reported significant changes to the company's collaboration on developing CD47 targeting agents. Via Benzinga Needham Maintains Buy Rating for I-MAB: Here's What You Need To Know August 17, 2022 Needham has decided to maintain its Buy rating of I-MAB (NASDAQ:IMAB) and lower its price target from $72.00 to $41.00. Shares of I-MAB are trading down 15.43% over the last 24 hours, at $6.74 per... Via Benzinga This Healthcare Stock Dipped Over 30%; Here Are 83 Biggest Movers From Yesterday August 18, 2022 Gainers Via Benzinga Why Blue Water Vaccines Is Trading Higher By Around 80%, Here Are 61 Stocks Moving In Wednesday's Mid-Day Session August 17, 2022 Gainers Blue Water Vaccines, Inc. (NASDAQ: BWV) shares jumped 79.5% to $4.57 after the company announced it plans to explore the potential development of a novel monkeypox vaccine using its norovirus... Via Benzinga AbbVie Calls Off Early-Stage Trial For I-Mab's CD47-Targeted Blood Cancer Candidate August 17, 2022 Via Benzinga Why Revlon Shares Jumped 90%; Here Are 83 Biggest Movers From Yesterday August 02, 2022 Gainers Liberty TripAdvisor Holdings, Inc. (NASDAQ: LTRPB) shares jumped 187.3% to close at $48.03 on Monday after gaining around 18% on Friday. Via Benzinga Stocks That Hit 52-Week Lows On Monday August 01, 2022 On Monday, 92 companies set new 52-week lows. Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session August 01, 2022 Via Benzinga This Biotechnology Stock Is Trading Lower By 77%, Here Are 62 Stocks Moving In Monday's Mid-Day Session August 01, 2022 Gainers Ontrak, Inc. (NASDAQ: OTRK) gained 102% to $1.3150. Ontrak is expected to report financial results for the second quarter on Tuesday, August 9, 2022. Via Benzinga < Previous 1 2 3 4 5 6 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.